Author: Popovic, Batric; Varlot, Jeanne; Metzdorf, Pierre Adrien; Jeulin, Hélène; Goehringer, François; Camenzind, Edoardo
Title: Changes in characteristics and management among patients with STâ€elevation myocardial infarction due to COVIDâ€19 infection Cord-id: kp5sc9iv Document date: 2020_7_15
ID: kp5sc9iv
Snippet: OBJECTIVES: To assess changes in characteristics and management among STâ€elevation myocardial infarction (STEMI) patients with coronavirus disease (COVIDâ€19) who underwent primary percutaneous coronary intervention. METHODS: Our prospective, monocentric study enrolled all STEMI patients who underwent PPCI during the COVIDâ€19 outbreak (n = 83). This cohort was first compared with a previous cohort of STEMI patients (2008–2017, n = 1,552 patients) and was then dichotomized into a nonâ€COV
Document: OBJECTIVES: To assess changes in characteristics and management among STâ€elevation myocardial infarction (STEMI) patients with coronavirus disease (COVIDâ€19) who underwent primary percutaneous coronary intervention. METHODS: Our prospective, monocentric study enrolled all STEMI patients who underwent PPCI during the COVIDâ€19 outbreak (n = 83). This cohort was first compared with a previous cohort of STEMI patients (2008–2017, n = 1,552 patients) and was then dichotomized into a nonâ€COVIDâ€19 group (n = 72) and COVIDâ€19 group (n = 11). RESULTS: In comparison with the preâ€outbreak period, patients during the outbreak period were older (59.6 ± 12.9 vs. 62.6 ± 12.2, p = .03) with a delayed seek to care (mean delay first symptomsâ€balloon 3.8 ± 3 vs. .7.4 ± 7.7, p < .001) resulting in a twoâ€fold higher inâ€hospital mortality (non COVIDâ€19 4.3% vs. COVIDâ€19 8.4%, p = .07). Among the 83 STEMI patients admitted during the outbreak period, 11 patients were infected by COVIDâ€19. Higher biological markers of inflammation (Câ€reactive protein: 28 ± 39 vs. 98 ± 97 mg/L, p = .04), of fibrinolysis (Dâ€dimer: 804 ± 1,500 vs. 3,128 ± 2,458 μg/L, p = .02), and antiphospholipid antibodies in four cases were observed in the COVIDâ€19 group. In this group, angiographic data also differed: a thrombotic myocardial infarction nonatherosclerotic coronary occlusion (MINOCA) was observed in 11 cases (1.4% vs. 54.5%, p < .001) and associated with higher postâ€procedure distal embolization (30.6% vs. 72.7%, p = .007). The in hospital mortality was significantly higher in the COVIDâ€19 group (5.6% vs. 27.3%, p = .016). CONCLUSION: The COVIDâ€19 outbreak implies deep changes in the etiopathogenesis and therapeutic management of STEMI patients with COVIDâ€19. The impact on early and longâ€term outcomes of systemic inflammation and hypercoagulability in this specific population is warranted.
Search related documents:
Co phrase search for related documents- acute mi myocardial infarction and long early term: 1
- acute mi myocardial infarction and long term short: 1
Co phrase search for related documents, hyperlinks ordered by date